Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Aditx Therapeutics Inc
Nieuws
Aditx Therapeutics Inc
ADTX
NAS
: ADTX
| ISIN: US0070251097
14/11/2024
0,349 USD
(+0,29%)
(+0,29%)
14/11/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
14 augustus 2024 ·
Evofem Biosciences Announces Financial Results for the Second Quarter of 2024
· Persbericht
23 juli 2024 ·
Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1
· Persbericht
27 juni 2024 ·
Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare
· Persbericht
15 mei 2024 ·
Evofem Biosciences Announces Financial Results for the First Quarter of 2024
· Persbericht
27 maart 2024 ·
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023
· Persbericht
7 maart 2024 ·
For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy
· Persbericht
1 februari 2024 ·
Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023
· Persbericht
14 juni 2022 ·
Premier Medical Laboratory Services Now Offering AditxtScore™ Personalized Immune Test for COVID-19
· Persbericht
5 oktober 2021 ·
AiPharma Signs Binding Agreement To Sell To Aditxt Inc (Nasdaq: ADTX). AiPharma Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.
· Persbericht
15 juni 2021 ·
Aditxt Set to Join Russell Microcap® Index
· Persbericht
6 mei 2021 ·
Aditxt Signs Channel Partner Agreement with Meridian HSN to Make AditxtScore™ for COVID-19 Available to its Network of Healthcare Provider Partners
· Persbericht
3 mei 2021 ·
Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA
· Persbericht
13 april 2021 ·
Aditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer
· Persbericht
6 april 2021 ·
HealthBar Becomes AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services
· Persbericht
1 april 2021 ·
Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers
· Persbericht
24 maart 2021 ·
Aditxt to Initiate First-In-Human Clinical Trials with its Therapeutics Programs in Psoriasis by Year-End
· Persbericht
4 maart 2021 ·
Eazy Testing Inc. Becomes AditxtScore™ Channel Partner, to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring with its Walk-In, Concierge, and Pre-Flight Services
· Persbericht
29 januari 2021 ·
Immunologist and Clinical Transplant Expert, Dolly B. Tyan, PhD, Joins Aditxt as Senior VP of Clinical Development - Transplantation
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe